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ABSTRACT 
Purpose: Laparoscopic Roux-en-Y gastric bypass (LRYGB) and laparoscopic vertical sleeve 
gastrectomy (LVSG), have been proposed as cost effective strategies to manage morbid obesity. 
This aim of this meta-analysis was to compared the postoperative weight loss outcomes reported 
in randomised control trials (RCTs) for LVSG versus LRYGB procedures. 
 
Material and Methods: RCTs comparing the weight loss outcomes following LVSG and 
LRYGB in adult population between January 2000 and November 2015 were selected from 
PubMed, Medline, Embase, Science Citation Index, Current Contents, and the Cochrane 
database. The review was prepared in accordance with Preferred Reporting of Systematic 
Reviews and Meta-Analyses (PRISMA). 
 
Results: Nine unique RCTs described over 10 publications involving a total of 865 patients 
(LVSG n=437, LRYGB n=428) were analyzed. Postoperative follow up ranged from 3 months to 
5 years. Twelve-month excess weight loss for LVSG ranged from 69.7% to 83%, and for 
LRYGB, ranged from 60.5% to 86.4%. A number of studies reported slow weight gain between 
the 2nd and 3rd years of postoperative follow-up ranging from 1.4 to 4.2% EWL. This trend was 
seen to continue to 5 years postoperatively (8% to 10% EWL) for both procedures.  
 
Conclusions: In conclusion, LRYGB and LVSG are comparable with regards to the weight loss 
outcomes in the short term, with LRYGB appearing achieving slightly greater weight loss. Slow 
weight recidivism is observed after the first postoperative year following both procedures. Long-
term reporting of outcomes obtained from well-designed studies using ITT analyses are 
identified as a major gap in the literature at present. 
INTRODUCTION 
Obesity is fast becoming the one of the most significant health problems facing the modern 
world, representing a major cause of morbidity, disability and early mortality. According to the 
World Obesity Federation adult obesity is now more common than under-nutrition with 670 
million of the world’s population now considered obese (BMI >30kg/m2) and a further 98 
million severely obese (>35kg/m2)[1]. In countries such as the United States, Mexico, Australia 
and New Zealand between a quarter and a third of their population are now considered to be 
obese[2].  
 
Obesity is associated with development of chronic health conditions such as Type 2 Diabetes, 
cardiovascular disease and some forms of cancer[1]. In addition to the health burden to the 
individual, there is a significant and growing economic burden associated with obesity.  It is 
therefore essential that effective population-based prevention strategies along with sustainable 
individual management approaches are being urgently sought to reduce the burden of disease and 
economic demands caused by widespread obesity. Bariatric surgical procedures, such as 
laparoscopic Roux-en-Y gastric bypass (LRYGB) and laparoscopic vertical sleeve gastrectomy 
(LVSG), are increasingly being utilized as cost-effective and efficacious strategies to manage 
obesity related chronic disease and metabolic conditions in the moderately to severely obese 
individuals[2-5].  
 
This aim of this systematic review and meta-analysis is to study the peer review literature 
regarding postoperative weight loss outcomes reported from randomised control trials (RCTs) 
comparing LVSG and LRYGB bariatric procedures. 
 MATERIALS AND METHODS 
Inclusion and Exclusion Criteria 
RCTs comparing clinical outcomes of elective LVSG and LRYGB procedures in adult subjects 
(>16 years) that reported weight loss outcomes were reviewed. Qualitative review was 
performed on all studies that met inclusion criteria, and meta-analyses were run on outcome 
variables where numbers and methods of reporting were sufficient to allow statistical analysis.  
 
Search Strategies and Data Collection 
Electronic databases (Medline, Pubmed, EMBASE, CINAHL, Cochrane Register of Systematic 
Reviews, Science Citation Index) were cross-searched for RCTs published between 2000 and 
November 2015 to capture the studies since Regan et al’s description of the LVSG as a stand-
alone procedure[6]. Search terms were selected for each search engine to optimize identification 
of all published papers meeting the inclusion criteria. Limits were set to RCTs and adult patients 
(>16yrs) to reflect the inclusion criteria. Search strategies utilized included combinations of 
"laparoscopy"[MeSH Terms] OR "laparoscopy"[All Fields] OR "laparoscopic"[All Fields]), 
"gastric sleeve"[All Fields] OR "sleeve gastrectomy"[All Fields] AND "Roux-en-y"[All Fields] 
OR "*gastric bypass"[All Fields] AND "outcomes"[All Fields]. Reference lists of review articles 
were examined for additional citations. Authors of included papers were contacted by email for 
clarification or additional information where required. The review was prepared in accordance 
with Preferred Reporting of Systematic Reviews and Meta-Analyses (PRISMA). Two authors 
(EO and MAM) independently appraised identified studies to confirm compliance with agreed 
inclusion criteria. One author (EO) undertook the data extraction. The authors were not blinded 
to the source of the document or authorship for the purpose of data extraction. The data were 
compared and consensus was achieved through discussion or contact with corresponding authors 
when required. The Jadad scoring system[7] was used to assess the methodological quality of 
identified studies.  
 
Statistical Analysis 
Meta-analyses were performed weighted mean differences (WMDs). Random effects model 
(REM), developed by DerSimonian and Laird[8] using the inverse variance weighted method 
approach and the inverse variance heterogeneity (IVhet) model developed by Doi et al[9] were 
used to combine the data to estimate the common effect size of the outcome variables. 
Heterogeneity among the effect size measures was assessed using the Q statistic[10, 11] and I2 index[12-14]. 
Funnel plots were synthesized in order to assess for the presence of publication bias in the meta-
analysis. Standard error was plotted against the treatment effects (Log OR for the dichotomous 
and WMD for continuous variables respectively)[15] to allow 95% confidence interval limits to 
be displayed. Estimates were obtained using computer programs written in R package for the 
random effects model, while the MetaXL program was used for computations under the inverse 
variance heterogeneity model referred to the paper[9, 16]. All forest plots are for the estimates of 
the effect size obtained from the random effects model and were obtained using the ‘rmetafor’ 
package[16]. A significance level of 5% ( =0.05) was applied to tests of hypotheses. 
 
RESULTS 
Included Studies 
Search outcomes identified 478 citations through literature searches (k=473) and hand searches 
of bibliographical information (k=5). After removal of duplicates and screening of abstracts, 57 

full text articles were retrieved and assessed against eligibility criteria. Of the 48 studies 
excluded, 39 were found not to be in conformity with RCT study design, 11 were reviews 
(including existing systematic reviews or meta-analyses), three studies reported different 
outcomes or follow up time frames of otherwise eligible studies, one did not report on clinical 
outcomes, one described outcomes of bariatric procedures in an adolescent population, one 
reported clinical outcomes of LVSG versus open LRYGB, while another reported LVSG versus 
mini gastric bypass. In addition, two protocols describing studies eligible for inclusion in this 
meta-analysis that currently in progress were also located[17, 18]. Nine unique RCTs described 
over 10 publications involving a total of 865 patients (LVSG n=437, LRYGB n=428) reported 
postoperative weight loss in sufficient detail for inclusion in the systematic review and meta-
analysis, as reported data allowed (Figure 1). 
 
Included studies represented a range of countries internationally including China[19, 20], 
Finland[21, 22],  Switzerland[23], Greece[24, 25], Israel(26), France[27] and Brazil[28]. All 
included studies were published within the last five years reporting on studies conducted 
between 2005 and 2015. Postoperative follow up ranged from 3 months to 5 years 
postoperatively, reporting in intervals ranging from 1 month to 1 year. Included studies were of a 
moderate methodological quality, with an average Jadad score of 3 (range 2 to 5). All studies 
reported randomization methods and accounted for all patients throughout the follow up period, 
while blinding was reported to have occurred in only one study[26]. No study described 
preoperative weight loss dietary interventions (i.e. very low energy/calorie diets), however three 
studies stated that full multidisciplinary assessments and preoperative workups (including 
nutritional, psychological, endocrine, cardiology) were undertaken[21, 27, 28]. Table 1 outlines 
the characteristics of included studies.  
 
Loss to follow up 
Considering loss to follow up rates across all studies, a median of 93% (range 32% to 100%) of 
participants continued to be followed up for the full study duration. Four studies[19, 20, 24, 25] 
retained patients throughout their reported follow up periods either through use of intention to 
treat (ITT) statistics and/or no loss of patients to follow up. Though retaining 100% of patients at 
one year follow up, Peterli et al[23] reported the highest rate of loss to follow-up with only 112 
(51.6%) at 2 years and 70 (32%) at three years of the original 217 patients who commenced the 
SM-BOSS study continuing: Reported weight outcomes were limited to one year postoperative 
follow up. 
 
BMI and Weight at baseline 
All studies reported baseline BMI. These ranged from around 32 to 39 kg/m2 in studies 
conducted in China[19, 20] to 42 to 45 kg/m2 in the other countries represented by the included 
studies [21-28]: this reflects the anthropometric differences and definitions of obesity in different 
cultural groups. 
 
Seven studies[19, 23-28] also reported weight in kilograms at baseline. Again, the Chinese 
study[19] reporting this outcome disclosed a lower baseline weight (88-94 kg) than the papers 
from other countries which revealed consistent preoperative weights of ~120-130kg. 
 
Percent Excess Weight Loss (%EWL)  
Systematic Review 
%EWL was the most commonly reported weight loss outcome, being reported in seven 
studies[19-22, 24, 25, 27, 28]. The computation of this, however, was defined in only one 
study[19] but was assumed to be consistent to all studies. All studies reported %EWL in means, 
and SD was not consistently provided. 
 
Reported follow up intervals on %EWL ranged from one month (k=3) to four years (k=1) 
postoperatively, with three (k=6), six (k=4) and twelve (k=5) month intervals, and annual follow 
up thereafter (2 yrs k=2; 3 yrs k=3).  
 
Considerable variation in %EWL achieved and trends in %EWL reported during the follow up 
periods were noted between studies reporting this outcome. All studies reported trends of 
consistent and increasing losses of percent excess weight to 12 months follow-up irrespective of 
procedure performed. Weight loss achieved in LVSG at 12 months ranged from 69.7%EWL[24] 
to 83%EWL[27] (median 73.9 %EWL), with similar outcomes seen with LRYGB over the same 
time period (median 80.4 %EWL, ranging from 60.5%EWL[24] to 86.4%EWL[19]). 
 
In the three studies[19, 20, 25] that reported %EWL outcomes between 1 and 2 years 
postoperatively, excess weight loss was reported to continue (LVSG 79.6% to 84.9%EWL, 
LRYGB 86.4% to 95.1%EWL[19]), stabilize (LVSG 72.9% to 73.2%EWL, LRYGB 65.6% to 
65.3%EWL[25]) or be slowly regained (LVSG 73.9% to 69.4%EWL, LRYGB 84.5% to 
81.2%EWL[20]). These same three studies[19, 20, 25] reported slow weight gain between the 
second and third years of postoperative follow up (ranging from 1.4 to 4.2%EWL regain). This 
trend was seen to continue to 5 years postoperatively where 8% to 10% of EWL was put on 
during the follow-up period[20]. Rates of weight regain appear to be similar within intervention 
groups within studies irrespective of surgical procedure. 
 
Helmio et al[22], Yang et al[19] and Zhang et al[20] reported superior %EWL achieved with 
LRYGB procedure i.e. 52.9%EWL vs 49.4%EWL at 6 months[22], 92.3%EWL vs 81.9%EWL 
at 3 years[19]  and 76.2%EWL vs 63.2%EWL at 5 years[20] for LRYGB and LVSG 
respectively. Conversely Karamankos et al[24], Kehagias et al[25] and Vix et al[27] report 
higher %EWL at the completion of study follow-up was achieved with LVSG i.e. 69.7 vs 
60.5%EWL[24] and  83 vs 80.4%EWL[27] at 12 months, and 68.5 vs 62.1%EWL at 3 years[25] 
for LVSG vs LRYGB respectively (Figures 2a and 2b).  
 
 
Meta-analysis 
Three studies[24, 27, 28] provided sufficient data to allow meta-analysis to be performed on 
%EWL at 1 month, representing 170 patients (LVSG n=89; LRYGB n=81). A non-statistically 
significant reduction in WMD was observed in favor of LRYGB (WMD 0.71; 95% CI -2.69, 
4.11; p=0.7) using the REM, while the IVhet model provided a similar but more conservative 
estimate (WMD= 0.84; 95% CI -2.58, 4.25; p=0.6). Moderate heterogeneity was observed 
(Q=3.81 p=0.1; I2 =47.4%). 
 
Four studies(22, 24, 27, 28) representing 403 patients (LVSG n=211; LRYGB n=192) provided 
sufficient data to allow meta-analysis to be performed on %EWL at 3 month. %EWL favored 
LRYGB (WMD 1.15; 95% CI -3.26, 5.56; p=0.6) using the REM, while the IVhet model 
provided a considerably different effect estimate though 95% CI remained similar to that of the 
REM (WMD= 0.43; 95% CI -3.98, 4.85, p=0.8). Moderate and statistically significant 
heterogeneity was observed (Q=10.96 p=0.01; I2 =73.9%). 
 
Three studies[22, 24, 27] provided sufficient data to allow meta-analysis to be performed on 
%EWL at 6 month, representing 351 patients (LVSG n=186; LRYGB n=165). A non-
statistically significant reduction in WMD was observed in favor of LRYGB (WMD 0.51; 95% 
CI -4.97, 6.0; p=0.8) using the REM, while the IVhet model provided a considerably different 
effect estimate though 95% CI remained similar to that of the REM (WMD= 0.18; 95% CI -5.77, 
6.12, p=0.9). A significant degree of heterogeneity was observed (Q=7.15 p=0.03; I2 =69.26%). 
 
Only two studies[24, 27] provided sufficient data to allow meta-analysis to be performed on 
%EWL at 12 months, representing 111 patients (LVSG n=57; LRYGB n=54). A statistically 
significant reduction in WMD was observed in favor of LRYGB (WMD 7.61; 95% CI -0.12, 
15.3; p=0.05) using the REM. The estimates obtained using the IVhet model provided identical 
results as the REM. No heterogeneity was identified (Q=0.51 p=0.5; I2 0% not computable) 
(Figure 3).  
 
Total Weight loss 
Systematic Review 
Total weight loss was reported by three studies[19, 23, 26]: Keider et al[26] reported this as their 
only primary weight loss outcome, and was the only study to report this outcome on more than 
one time point post baseline. They observed an average total weight loss of ~24 kg and ~21 kg at 
3 months and total of ~34 kg and ~30 kg weight loss at 12 months in the LVSG and LRYGB 
groups respectively[26]. Peterli et al[23] reported total weight loss between baseline and 12 
months to be ~36-37 kg post LVSG and ~40 kg post LRYGB, and state no further weight loss in 
those continuing follow up to the second and third year postoperatively. Finally Yang et al[19] 
reported total weight loss of ~25 kg post LVSG and ~30 kg post LRYGB at 3 years.  
 
The average weight of subjects at the end of the 12 month follow up period was around 85-90 kg 
irrespective of which procedure was performed, and no procedure demonstrated superior weight 
loss outcomes to the other. The final weights at 3 years follow up reported by Yang et al[19] are 
lower at ~60-65 kg, however this cannot be directly compared to the 12 months results due to the 
ethnic differences between subjects, and should rather be interpreted in view of the lower 
baseline body weights in the Chinese subjects.  
 
Meta-analysis 
Only two studies[23, 26] provided sufficient information to allow meta-analysis to be performed 
on total weight loss at 12 months postoperatively: this represents 254 patients (LVSG n=125; 
LRYGB n=129). The WMD demonstrates no significant difference in total weight loss outcome 
(WMD 0.26; 95% CI -5.16, 5.69; p=0.9). While also not statistically significant, the IVhet model 
provides a WMD of 0.70, CI -4.80, 6.19 (p=0.8). Minimal heterogeneity was observed (Q=1.42 
p=0.2; I2 29.8%). 
 
BMI changes throughout follow up  
Systematic Review 
BMI was reported in seven[19-26, 28] of the eight eligible studies at a range of time points 
between 1 month and 5 years postoperatively. Most studies reported results as means (±SD), 
while one reported median and range[21, 22] and another reported means with a range[28]. 
 
A review of the trends in BMI change throughout the follow up period indicates consistent 
weight loss in the order of 9.7 to 16.2 kg/m2 (average 12.7 kg/m2) post LVSG and 10.6 to 15.1 
kg/m2 (average 13.0 kg/m2) post LRYGB in the 12 month postoperative period by the studies 
reporting this outcome[20, 23, 24, 26]. In the studies[19, 20, 23, 25] that report BMI outcomes 
at3 year follow up, reduction in BMI from baseline range from 9 to 15.3 kg/m2 (average 11.2 
kg/m2) post LVSG and from 10.3 to 14.5 kg/m2 (average 12.3 kg/m2) post LRYGB. Between the 
1 and 3 year time periods BMI is seen to stabilize and a slow upward trend in the weight gain in 
the order of 0.5 to 1.5 kg/m2 and 0.5 to 1.3 kg/m2 in LVSG and LRYGB respectively is 
noticed[20, 23]. This trend is seen to continue in to five years in the one study[20] that continue 
to follow up their patients with a gain of 3.4 kg/m2 post LVSG and 2.7 kg/m2 post LRYGB when 
considered from the lowest point at 12 months. Overall weight change represented by BMI 
appears reasonably comparable between procedures, with perhaps a slightly slower regain and 
marginally greater weight loss achieved with LRYGB on direct comparison. (Figures 4a and 4b).  
 
Percent BMI loss (%BMIL) 
Systematic Review 
Three studies[23, 25, 27] reported %BMIL, reporting on varying time points from one months to 
three years postoperatively. Vix et al[27], the only study to report on multiple time points within 
the first postoperative year, described consistent and ongoing %BMIL at 1, 3, 6 and 12 month 
intervals in both LVSG and LRYGB. Peterli et al[23] reported outcomes between 1 and 3 years 
postoperatively and demonstrate what appears to be a stabilisation of %BMIL at ~ 70%BMIL 
following the first postoperative year. 
 
Those that reported data at the same time points reported reasonably consistent outcomes at 12 
months with ~70%BMIL for LVSG and ~70-75%BMIL for LRYGB[23, 27]. Greater variation 
in %BMIL between procedures was reported at 3 years between studies in the LRYGB groups 
with 61.4%BMIL reported by Kehagias et al[25], and 74.1%BMIL reported by Peterli et al[23]. 
%BMIL results at 3 years were consistently reported at ~70% for LVSG between the same 
studies[23, 25]. (Figures 5a and 5b).  
 
Publication Bias 
Funnel plots do not suggest the presence of publication bias as all points remain within the 95% 
CI limits in plots of Log OR against standard error. (Figure 6). 
 
DISCUSSION 
The results of this systematic review of RCTs reporting weight loss outcomes of up to 5 years 
postoperatively suggest that LRYGB and LVSG achieve comparable weight loss within the first 
postoperative year, and thereafter stabilize before transforming into slow trend towards slow 
weight recidivism. LRYGB may provide a greater degree of weight loss moving from 2 to 5 
years postoperatively compared to LVSG, however due to the low number of RCTs studies 
reporting long term weight outcomes these results require further confirmation. Where meta-
analysis was able to be performed, with the exception of %EWL at 12 months, no statistically 
significant differences were seen in weight loss outcomes. In the case of %EWL at 12 months, 
the meta-analysis favored LRYGB for superior weight loss outcomes compared to LVSG, 
however this should be viewed with caution due to the low number of studies for this time point 
(k=2) and the subsequently low number of study participants compared to other meta-analyses in 
this study (n=111).  
 
Yip et al[29] in their systematic review and meta-analysis of RYGB versus (V)SG in obese 
patients with type 2 diabetes found comparable weight loss outcomes (%EWL and %EBMIL) 
between the procedures at 3 and 12 month follow-up, however longer term weight loss was not 
addressed as included studies did not report beyond three years postoperative follow up. Zhang 
et al [30] reviewed weight loss outcomes over a variety of follow-up intervals in a similar 
fashion to the present work but with different inclusion criteria, and likewise reported a trend for 
comparable weight loss outcomes between LRYGB and LVSG within the first year, with the 
separation in greater sustained weight loss becoming more apparent with LRGYB beyond this 
time point to 4 years follow up. Other systematic reviews and meta-analyses reporting weight 
loss outcomes at 2 year follow-up post-surgery[31] and for non-specified follow up time 
periods[32, 33] also report that greater weight loss outcomes were achieved with LRYGB 
compared to LVSG. However, it should be noted that these analyses included a variety study 
methodologies - including observational, cohort, case control studies as well as RCTs (level I to 
level IV evidence) and therefore the overall conclusions are unreliable and invalid from these 
analyses. The one meta-analysis currently in the literature using data solely from RCTs 
investigating this topic in patients exclusively in patients type 2 diabetes also found that %EWL 
was greater in LRYGB compared with LVSG[34].  
 While the results of this review suggest LRYGB and LVSG appear to be efficacious in bringing 
about desired weight loss in the short term, the trends described suggest that weight recidivism 
over time is a common feature to both procedures. Indeed Cooper et al[35] have recently 
described between 21% and 29% regain after the first year in patients who have undergone 
RYGB, with excessive weight gain reported in around one third of the 300 patients they followed 
for a mean of 7 years. Similarly weight gain following LVSG has also been reported between 15 
to 75% at 5 year follow-up[36].  
 
The aetiology driving weight recidivism for both procedures is considered to be multifactorial. 
Anatomical changes, such as an enlargement of the gastric pouch/gastrojejunostomy diameter 
may occur, in both procedures that reduce the restriction[37, 38]. Additionally the development 
of gastro-gastric fistulae have also been described to occur after RYGB which may further 
negate the effect of volume restriction[37]. Roux-en-Y gastric bypass has been associated with 
changes to gastric hormones such as increased Peptide YY (PYY), and animal studies have 
suggested that over time the reversal of early postoperative modifications to the PYY:leptin ratio 
may account for weight regain through a variety of mechanisms that promote energy 
conservation[39, 40]. Similarly gherlin levels, which stimulate appetite and have been shown to 
decrease initially post RYGB, are observed to slowly increase in the follow up period and may 
also contribute to weight regain as appetite suppression declines[37]. Similar mechanisms are 
hypothesized to occur post LVSG, however conflicting research presently exists and further 
studies are required[38, 41-43]. A further physiological mechanism currently being investigated 
is the role bile acid signalling that occurs following LVSG and its potential role in facilitating 
weight loss and metabolic improvements, particularly around fatty liver[43-45]. Failure to adhere 
to appropriate dietary behaviours post-surgery is also a significant contributor to weight regain in 
both procedures. Dietetic follow up has been observed to wane after two years postoperative 
follow up, with only 3% remaining in regular dietetic follow up at 5 years after RYGB[46].  
Similarly, ongoing postoperative psychological support to facilitate lifetime behaviour change 
along with the management of concurrent psychological issues such as depression have been 
identified as important factors in sustained weight loss post bariatric surgery[37]. This is 
particularly the case for those patients identified as having binge eating or other maladapted 
eating behaviours preoperatively[47]. Structured postoperative programs providing 
psychological and combined pharmacological and lifestyle change interventions have been 
shown to be effective at reducing postoperative weight regain following a range of bariatric 
procedures[48-50]. These findings also highlight need for thorough preoperative dietetic and 
psychological assessment to identify behaviours and underlying conditions that may represent 
risks for weight recidivism postoperatively.  
 
Our review, along with much of the literature in this area, suggests LRYGB may provide a 
comparatively greater degree of weight loss than LVSG in the long term. Considering the 
multiple mechanisms by which LRYGB facilitates weight compared to those of LVSG, it seems 
reasonable that the additional component of malabsorption may account for some of the results 
observed in this and other studies comparing the weight loss outcomes of each procedure. To 
date the longest follow up time period described by an RCT is 5 years. Longer term studies are 
required to better understand this trend, along with improved surveillance and reporting on the 
number of patients who go on to have further bariatric procedures to manage weight recidivism 
to allow an accurate assessment of the cost-effectiveness of bariatric surgery as a strategy in the 
battle against obesity.   
 
Another issue that requires further description in the literature is attrition from longer term 
studies investigating weight loss outcomes in bariatric patients. It is interesting to note in the 
present work that of the four studies[19, 20, 23, 25] that report outcomes at 3 to 5 years 
postoperatively there is an obvious decline in number with each year of follow-up, ranging from 
32 to 95%. While some studies manage loss to follow up by reporting results using intention to 
treat (ITT) statistics[19, 20, 24, 25], others[23] report only time points where 100% follow up is 
achieved (12 months). Loss to follow up creates major issues in accurately describing long term 
weight loss outcomes following bariatric procedures, and is an issue that needs innovative 
measures to address, both to improve the quality of research in this area and to achieve optimal 
clinical practice, as sustained follow up appears to be related to improved weight outcomes 
postoperatively[51]. 
 
There are a broad range of ethnicities covered by the included studies in this paper, which 
highlights the issue of an appropriate classification for obesity within different ethnic groups, and 
the potential for this to alter eligibility criteria for bariatric surgery in patients with diverse ethnic 
background. There is an increasing acknowledgement that having universal BMI cut offs to 
define obesity may not adequately reflect risk differences between ethnicity and gender[52]. A 
number of societies have already adopted ethnic specific BMI ranges in their clinical guidelines 
and definitions of obesity to reflect the literature in this area since the publication of WHO’s 
2004 consensus paper maintaining an international standard[53-55]. These issues highlight the 
need for adoption of standardized measures of weight loss such as %EWL or %BMI in obesity 
and bariatric surgery research to ensure a standardized comparison can validly be made between 
studies of conducted in different ethnic groups and genders.  
 
LIMITATIONS 
We acknowledge, there are a number of potential factors that may confound our results obtained 
and conclusions drawn. First, the included studies covered a diverse range of ethnicities and 
comorbid conditions. We purposely did not control for these issues in an attempt to better reflect 
‘real life’ clinical practice, however it is possible that with different metabolic responses in some 
studies with a high proportion of diabetic patients, or with different relative degrees of obesity in 
different ethnic groups, that this may impact the conclusions drawn. In any case it is likely to 
have contributed to the heterogeneity inherent in some of the described outcomes. Second is the 
slightly different surgical techniques described in the methodologies sections of the included 
studies. This highlights the variation in surgical practice for otherwise standard procedural 
terminology: this has obvious impacts for the interpretation of weight loss between studies 
outcomes. Third is the short duration of follow up reported by most studies. Of the nine studies 
meeting the criteria for inclusion, only three reported outcomes beyond 12 months 
postoperatively. In seeking long-term solutions for obesity management, it is essential that long-
term postoperative outcomes be reported for sufficient durations in sufficient number of patients 
to allow informed decisions about to be made. Fourth is the potential impact of the moderate 
methodological quality of the included studies. Finally there remain a relatively small number of 
RCTs investigating this topic, and even fewer from which the data required to perform meta-
analysis is available. This poses a limitation to the statistical power of the analyses performed. 
 CONCLUSIONS 
In conclusion, this systematic review and meta-analysis of RCTs suggests that LRYGB and 
LVSG are comparable with regards to the weight loss outcomes in the short term, with LRYGB 
appearing achieving slightly greater weight loss over the longer period of time, however, more 
RCTs are required to confirm this. Slow weight recidivism is observed after the first 
postoperative year following both procedures. Long-term reporting of outcomes obtained from 
well-designed studies using ITT analyses are identified as a major gap in the literature at present. 
Lastly informed decision making based on true-cost benefits analysis for both of these 
procedures is required to streamline the best long-term weight loss procedure.  
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